Genetic Variants of SARS-CoV-2—What Do They Mean?

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557

Spike mutation D614G alters SARS-CoV-2 fitness

Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,116

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint

Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313

We shouldn’t worry when a virus mutates during disease outbreaks

Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168

Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection

Singh, M., Adame, O. B., Nickas, M., Robison, J., Khatchadourian, C., & Venketaraman, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833355 · Cited by 19

Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles

Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2023) · International Journal of Veterinary Science and Medicine · doi:10.1080/23144599.2023.2222981 · Cited by 17

Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall–Winter 2022–2023: A Cross-Sectional Retrospective Study

Kopel, H., Bogdanov, A., Winer-Jones, J. P., Adams, C., Winer, I. H., Bonafede, M., Nguyễn, V. H., & Mansi, J. A. (2024) · Diseases · doi:10.3390/diseases12010016 · Cited by 17

The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants

Kim, D., Keskinocak, P., Pekgün, P., & Yildirim, I. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-11060-8 · Cited by 18

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex

Ching, W.-Y., Adhikari, P., Jawad, B., & Podgornik, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710091 · Cited by 17

Characterizing SARS-CoV-2 genome diversity circulating in South American countries: Signatures of potentially emergent lineages?

Muñoz, M., Patiño, L. H., Ballesteros, N., Paniz‐Mondolfi, A., & Ramírez, J. D. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.073 · Cited by 16

Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant

Rosato, A. E., Msiha, E., Weng, B., Mesisca, M. K., Gnass, R., Acosta-Gnass, S. I., Bol, C., Tabuenca, A. D., & Rosato, R. R. (2022) · Pathology · doi:10.1016/j.pathol.2022.01.001 · Cited by 16

Open science, COVID-19, and the news: Exploring controversies in the circulation of early SARS-CoV-2 genomic epidemiology research

Molldrem, S., Hussain, M., & Smith, A. K. J. (2021) · Global Public Health · doi:10.1080/17441692.2021.1896766 · Cited by 16

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

Aparicio, B., Casares, N., Egea, J., Ruiz, M., Llópiz, D., Maestro, S., Olagüe, C., González‐Aseguinolaza, G., Smerdou, C., de Cerio, A. L.-D., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1978823 · Cited by 16

The Dominance of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 and Its Sublineages and Associations with Mortality during the COVID-19 Pandemic in India between 2020 and 2021

Venkatraja, B., Gali, S., & Kumar, B. K. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0812 · Cited by 16

Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage

Shukla, P., Pandey, P., Prasad, B., Robinson, T., Purohit, R., D'Cruz, L. G., Tambuwala, M. M., Mutreja, A., Harkin, J., Singh, T., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab496 · Cited by 16

The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants

Damasceno, D. H. P., Amaral, A. A., Silva, C. A., & Silva, A. C. S. E. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210902094254 · Cited by 15

Analysis of SARS-COV2 spike protein variants among Iraqi isolates

Sabir, D. K. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101420 · Cited by 15

Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study

Chudzik, M., Babicki, M., Kapusta, J., Kołat, D., Kałuzińska‐Kołat, Ż., Mastalerz–Migas, A., & Jankowski, P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050706 · Cited by 15

Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study

Kim, Y.-Y., Choe, Y. J., Kim, J., Kim, R. K., Jang, E. J., Lee, H., Yi, S., Lee, S., & Park, Y.-J. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e87 · Cited by 15

Investigating the FLiRT variants of COVID-19: Is it an emerging concern?

Aden, D., & Zaheer, S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155542 · Cited by 15

Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screening

Schneider, F. S., Molina, L., Picot, M., l’Helgoualch, N., Espeut, J., Champigneux, P., Alali, M., Baptiste, J., Cardeur, L., Carniel, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-04826-7 · Cited by 15

Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model

Chen, Y., Chang, Y.-H., Pathak, N., Tzou, S.-C., Luo, Y.-C., Hsu, Y.-C., Li, T., Lee, J.-Y., Chen, Y.-C., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1080897 · Cited by 15

A Global Mutational Profile of SARS-CoV-2: A Systematic Review and Meta-Analysis of 368,316 COVID-19 Patients

Yusof, W., Irekeola, A. A., Wada, Y., Rahman, E. N. S. E. A., Ahmed, N., Musa, N., Khalid, M. F., Rahman, Z. A., Hassan, R., Yusof, N. Y., et al. (2021) · Life · doi:10.3390/life11111224 · Cited by 14

Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks

Saldivar‐Espinoza, B., Macip, G., Garcia‐Segura, P., Mestres‐Truyol, J., Puigbò, P., Cereto‐Massagué, A., Pujadas, G., & García-Vallvé, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314683 · Cited by 15

ViruClust: direct comparison of SARS-CoV-2 genomes and genetic variants in space and time

Cilibrasi, L., Pinoli, P., Bernasconi, A., Canakoglu, A., Chiara, M., & Ceri, S. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac030 · Cited by 14

Quantitative SARS-CoV-2 tracking of variants Delta, Delta plus, Kappa and Beta in wastewater by allele-specific RT-qPCRPreprint

Lee, W. L., Gu, X., Armas, F., Chandra, F., Chen, H., Wu, F., Leifels, M., Xiao, A., Chua, F. J. D., Kwok, W. C., et al. (2021) · medRxiv · doi:10.1101/2021.08.03.21261298 · Cited by 14

CoV2K model, a comprehensive representation of SARS-CoV-2 knowledge and data interplay

Alfonsi, T., Khalaf, R. A., Ceri, S., & Bernasconi, A. (2022) · Scientific Data · doi:10.1038/s41597-022-01348-9 · Cited by 14

A Review on the Contemporary Status of Mutating Coronavirus and Comparative Literature Study of Current COVID-19 Vaccines

Jahangir, M. A. (2021) · International Journal of Pharmaceutics & Pharmacology · doi:10.31531/2581-3080.1000153 · Cited by 13

Are there medium to short-term multifaceted effects of the airborne pollutant PM2.5 determining the emergence of SARS-CoV-2 variants?

Baron, Y. M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110718 · Cited by 13

Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients

Garanina, E. E., Hamza, S., Stott-Marshall, R. J., Martynova, E. V., Markelova, M., Davidyuk, Y. N., Shakirova, V. G., Kaushal, N., Baranwal, M., Хаертынова, И. М., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.842232 · Cited by 13

COVID-19 in Women's health: Epidemiology

Jardine, J. E., & Morris, E. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.03.010 · Cited by 13

Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas

Bedoya-Sommerkamp, M., Medina-Ranilla, J., Rodriguez, V. H. C., Li-Soldevilla, R., Vera-Albújar, Á., & Garcia, P. J. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.383.8734 · Cited by 13

Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population

de León, U. A.-P., Avila-Vales, E. J., & Huang, K. (2022) · Viruses · doi:10.3390/v14010158 · Cited by 13

Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan

Abdullaev, A. A., Abdurakhimov, A., Mirakbarova, Z., Ibragimova, S., Tsoy, V., Nuriddinov, S., Akbarovna, D. D., Turdikulova, S. U., & Abdurakhmonov, I. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270314 · Cited by 13

Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis

Nagraj, S., Varrias, D., Romero, G. H., Santos, H. T., Karamanis, D., Sagris, D., Korompoki, E., Milionis, H. J., Palaiodimos, L., & Ntaios, G. (2022) · Stroke · doi:10.1161/strokeaha.122.040233 · Cited by 13

Network analysis uncovers the communication structure of SARS-CoV-2 spike protein identifying sites for immunogen design

Manrique, P. D., Chakraborty, S., Henderson, R. C., Edwards, R. J., Mansbach, R. A., Nguyen, K., Stalls, V., Saunders, C., Mansouri, K., Acharya, P., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105855 · Cited by 13

Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue

Varlas, V. N., Roxana Georgiana, B. O. R. S., Plotogea, M., Iordache, M. D., Mehedințu, C., & Cîrstoiu, M. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031949 · Cited by 14

Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19

Gobeil, P., Pillet, S., Boulay, I., Charland, N., Lorin, A., Cheng, M. P., Vinh, D. C., Boutet, P., der Most, R. G. V., Roman, F. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34728-1 · Cited by 13

Characterization of SARS-CoV-2 East Java isolate, Indonesia

Rantam, F. A., Prakoeswa, C. R. S., Tinduh, D., Nugraha, J., Susilowati, H., Wijaya, A. Y., Puspaningsih, N. N. T., Puspitasari, D., Husada, D., Kurniati, N. D., et al. (2021) · F1000Research · doi:10.12688/f1000research.53137.1 · Cited by 12

SARS-CoV-2 variants, a still unfinished story

Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas (English Edition) · doi:10.1016/j.vacune.2021.10.003 · Cited by 12

Attribute nonattendance in COVID‐19 vaccine choice: A discrete choice experiment based on Chinese public preference

Xiao, J., Wang, F., Wang, M., & Ma, Z. (2022) · Health Expectations · doi:10.1111/hex.13439 · Cited by 12

Lüftungskonzepte in Schulen zur Prävention einer Übertragung hochinfektiöser Viren (SARS-CoV‑2) über Aerosole in der Raumluft

Birmili, W., Selinka, H., Moriske, H., Daniels, A., & Straff, W. (2021) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-021-03452-4 · Cited by 12

Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing

Gurevich, Y., Ram, Y., & Hadany, L. (2022) · Evolution Medicine and Public Health · doi:10.1093/emph/eoac013 · Cited by 12

A Survey on Data-driven COVID-19 and Future Pandemic Management

Tao, Y., Yang, C., Wang, T., Coltey, E., Jin, Y., Liu, Y., Jiang, R., Fan, Z., Song, X., Shibasaki, R., et al. (2022) · ACM Computing Surveys · doi:10.1145/3542818 · Cited by 12

Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches

Parmar, M., Thumar, R., Sheth, J., & Patel, D. (2022) · Structural Chemistry · doi:10.1007/s11224-022-02027-6 · Cited by 12

COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity

David, S., Dorado, G., Duarte, E. L., David-Bosne, S., Trigueiro-Louro, J. M., & Rebelo‐de‐Andrade, H. (2022) · Immunogenetics · doi:10.1007/s00251-022-01261-w · Cited by 13

Cryo-EM Structures of the N501Y SARS-CoV-2 Spike Protein in Complex with ACE2 and Two Potent Neutralizing AntibodiesPreprint

Zhu, X., Mannar, D., Srivastava, S. S., Berezuk, A., Demers, J.-P., Saville, J. W., Leopold, K., Li, W., Dimitrov, D. S., Tuttle, K. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426269 · Cited by 12

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England

Chudasama, D. Y., Flannagan, J., Collin, S. M., Charlett, A., Twohig, K. A., Lamagni, T. L., & Dabrera, G. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.029 · Cited by 12

Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays

Velu, P., Cong, L., Rand, S., Qiu, Y., Zhang, Z., Zhang, J., Guo, J., Ruggiero, P., Sukhu, A. C., Fauntleroy, K. A., et al. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115789 · Cited by 11

Envisioning Post-pandemic Digital Neurological, Psychiatric and Mental Health Care

Khanna, A., & Jones, G. B. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.803315 · Cited by 11

Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima

Ko, K., Takahashi, K., Nagashima, S., Bunthen, E., Ouoba, S., Takafuta, T., Fujii, Y., Mimori, M., Okada, F., Kishita, E., et al. (2022) · Viruses · doi:10.3390/v14040720 · Cited by 11

Genomic landscape of alpha-variant of SARS-CoV-2 circulated in Pakistan

Fiaz, N., Zahoor, I., Saima, S., & Basheer, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276171 · Cited by 11

Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern

Iqbal, R., Khan, S., Ali, H. M., Khan, M., Wahab, S., & Khan, T. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.1060756 · Cited by 11

Variation in synonymous evolutionary rates in the SARS-CoV-2 genome

Sun, Q., Zeng, J., Tang, K. L., Long, H., Zhang, C., Zhang, J., Tang, J. Y., Xin, Y., Zheng, J., Sun, L., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1136386 · Cited by 11

Seasonal effects decouple SARS-CoV-2 haplotypes worldwide

Tomaszewski, T., Ali, M. A., Caetano-Anollés, K., & Caetano‐Anollés, G. (2023) · F1000Research · doi:10.12688/f1000research.131522.1 · Cited by 11

Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking

Cheng, Y., Ji, C., Zhou, H., Zheng, H., & Wu, A. (2023) · Viruses · doi:10.3390/v15051158 · Cited by 11

Bipolar ionization rapidly inactivates real-world, airborne concentrations of infective respiratory viruses

Sobek, E. A., & Elias, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293504 · Cited by 12

Moving Biosurveillance Beyond Coded Data Using AI for Symptom Detection From Physician Notes: Retrospective Cohort Study

McMurry, A., Zipursky, A. R., Geva, A., Olson, K. L., Jones, J. R., Ignatov, V., Miller, T. A., & Mandl, K. D. (2024) · Journal of Medical Internet Research · doi:10.2196/53367 · Cited by 11

Parallel Pandemics Illustrate the Need for One Health Solutions

Tucker, C. D., Fagre, A. C., Wittemyer, G., Webb, T. L., Abworo, E. O., & VandeWoude, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.718546 · Cited by 11

Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages

Mostefai, F., Gamache, I., N’Guessan, A., Pelletier, J., Huang, J., Murall, C. L., Pesaranghader, A., Gaonac’h-Lovejoy, V., Hamelin, D. J., Poujol, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826746 · Cited by 11

DirectDetect SARS-CoV-2 Direct Real-Time RT-PCR Study Using Patient Samples

Naranbat, D., Schneider, L., Kantor, R., Beckwith, C. G., Bazerman, L. B., Gillani, F. S., Sahu, S., Rapoza, K., Sam, S. S., Novitsky, V., et al. (2022) · ACS Omega · doi:10.1021/acsomega.1c05595 · Cited by 11

The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and meta-analysis

Baradaran, H. R., Dehghanbanadaki, H., Moradpour, F., Eshrati, B., Moradi, G., Azami, M., Ghadery, A. H., Nejad, M.-M. M., & Moradi, Y. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2102001 · Cited by 11

Ranking the effectiveness of non-pharmaceutical interventions to counter COVID-19 in UK universities with vaccinated population

Niu, Z., & Scarciotti, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-16532-5 · Cited by 12

A Perspective on COVID-19 Management

Pavelić, K., Pavelić, S. K., Brix, B., & Goswami, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081586 · Cited by 12

Generator based approach to analyze mutations in genomic datasets

Jain, S., Xiao, X., Bogdan, P., & Bruck, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00609-8 · Cited by 11

Rapid expansion of SARS-CoV-2 variants of concern is a result of adaptive epistasisPreprint

Garvin, M. R., Prates, E. T., Romero, J., Cliff, A., Gazolla, J. G. F. M., Pickholz, M., Pavicic, M., & Jacobson, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454981 · Cited by 10

Monkeypox virus: insights into pathogenesis and laboratory testing methods

Kumar, A., Singh, N. K., Anvikar, A. R., & Misra, G. (2024) · 3 Biotech · doi:10.1007/s13205-024-03920-z · Cited by 10

COVID-19, corticosteroids and public health: a reappraisal

Fernandes, M., & Brábek, J. (2021) · Public Health · doi:10.1016/j.puhe.2021.05.028 · Cited by 10

The basis of mink susceptibility to SARS-CoV-2 infection

Barua, A., Grot, N., & Pławski, A. (2022) · Journal of Applied Genetics · doi:10.1007/s13353-022-00689-w · Cited by 10

Robust Mutation Profiling of SARS-CoV-2 Variants from Multiple Raw Illumina Sequencing Data with Cloud Workflow

Lim, H. G.-M., Hsiao, S.-H., Fann, Y. C., & Lee, Y.-C. G. (2022) · Genes · doi:10.3390/genes13040686 · Cited by 10

Mortality in hospitalized older adults with COVID‐19 during three waves: A multicenter retrospective cohort study

Wong, E. K. C., Watt, J. A., Zou, H., Chandraraj, A., Zhang, A. W., Norman, R., Piggott, K. L., Straus, S. E., & Liu, B. (2022) · Health Science Reports · doi:10.1002/hsr2.603 · Cited by 10

Exploring the expanse between theoretical questions and experimental approaches in the modern study of evolvability

Draghi, J. A., & Ogbunugafor, C. B. (2022) · Journal of Experimental Zoology Part B Molecular and Developmental Evolution · doi:10.1002/jez.b.23134 · Cited by 10

Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493

Carter, C., Airas, J., & Parish, C. A. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108360 · Cited by 10

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening

Gorshkov, K., Vasquez, D. M., Chiem, K., Ye, C., Tran, B. N., de la Torre, J. C., Moran, T. M., Chen, C. Z., Martínez‐Sobrido, L., & Zheng, W. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00182 · Cited by 10

Assessment of COVID-19 Vaccine Acceptance and Reluctance Among Staff Working in Public Healthcare Settings of Saudi Arabia: A Multicenter Study

Maqsood, M. B., Islam, M. A., Qarni, A. A. A., Nisa, Z., Ishaqui, A. A., Alharbi, N. K., Almukhamel, M., Hossain, M. A., Fatani, N., Mahrous, A. J., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.847282 · Cited by 10

Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

Sönmezer, M. Ç., Dizman, G. T., Erul, E., Şahin, T. K., Sarıcaoğlu, T., Alp, A., Tanrıöver, M. D., Uzun, Ö., Ünal, S., & Akova, M. (2022) · Vaccines · doi:10.3390/vaccines10071140 · Cited by 10

N-Glycosylation Network Construction and Analysis to Modify Glycans on the Spike (S) Glycoprotein of SARS-CoV-2

Krishnan, S., & Krishnan, G. P. (2021) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2021.667012 · Cited by 9

The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil

Bittar, C., Possebon, F. S., Ullmann, L. S., Geraldini, D. B., da Costa, V. G., de Almeida, L. G. P., Sanches, P. R. D. S., Nascimento-Júnior, N. M., Cilli, E. M., Banho, C. Á., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.745310 · Cited by 10

Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants

Bai, W., Gu, Y., Liu, H., & Zhou, L. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.216 · Cited by 9

Environmental genomic surveillance of SARS-CoV-2 in wastewater in Rio de Janeiro, Brazil

Gonçalves-Brito, A. S., Magaldi, M., de Farias, B. O., Nascimento, A. P. A., Flores, C., Montenegro, K. S., de Carvalho, M. L., Gimenez, A., da Costa, V. D. S. C., Assunção, V., et al. (2023) · Journal of Water and Health · doi:10.2166/wh.2023.034 · Cited by 9

Pooling of Samples for SARS-CoV-2 Detection Using a Rapid Antigen Test

Salcedo, N., Harmon, A., & Herrera, B. B. (2021) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2021.707865 · Cited by 9

Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern

Salehi, M., Hosseini, H., Jamshidi, H., Jalili, H., Tabarsi, P., Mohraz, M., Karimi, H., Lotfinia, M., Aalizadeh, R., Mohammadi, M., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.030 · Cited by 9

Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia

Tembo, J. M., Egbe, F. N., Maluzi, K. F., Mulonga, K., Chilufya, M., Kapata, N., Mukonka, V., Simulundu, E., Zumla, A. I., Fwoloshi, S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.017 · Cited by 9

Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States

Ahmad, W., Ahmad, S., & Basha, R. M. (2022) · Gene · doi:10.1016/j.gene.2022.146774 · Cited by 9

Evaluation of Variant-Specific Peptides for Detection of SARS-CoV-2 Variants of Concern

Suddhapas, K., Choi, M. H., Shortreed, M. R., & Timperman, A. T. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00325 · Cited by 9

Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants

Stoehr, J. R., Jahromi, A. H., & Thomason, C. L. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.702960 · Cited by 10

Biologically grounded scientific methods: The challenges ahead for combating epidemics

Rivas, A. L., & Hoogesteijn, A. L. (2021) · Methods · doi:10.1016/j.ymeth.2021.09.001 · Cited by 9

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19

Malani, P., & Golub, R. M. (2021) · JAMA · doi:10.1001/jama.2021.0585 · Cited by 10

Genetic diversity and evolution of SARS-CoV-2 in Belgium during the first wave outbreakPreprint

Wawina-Bokalanga, T., Martí‐Carreras, J., Vanmechelen, B., Bloemen, M., Wollants, E., Laenen, L., Cuypers, L., Beuselinck, K., Lagrou, K., André, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.29.450330 · Cited by 9

The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality

Tomaszewski, T., Gürtler, V., Caetano-Anollés, K., & Caetano‐Anollés, G. (2022) · Methods in microbiology · doi:10.1016/bs.mim.2022.03.003 · Cited by 8

Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies

Abduljaleel, Z. (2025) · Biophysical Chemistry · doi:10.1016/j.bpc.2025.107413 · Cited by 8

Data-driven identification of SARS-CoV-2 subpopulations using PhenoGraph and binary-coded genomic data

Yang, Z.-K., Pan, L., Zhang, Y., Luo, H., & Gao, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab307 · Cited by 8

Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA

Russell, A., O’Connor, C., Lasek‐Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., & George, K. S. (2022) · Emerging infectious diseases · doi:10.3201/eid2803.211972 · Cited by 8

Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2

Wang, B., & Gamazon, E. R. (2022) · iScience · doi:10.1016/j.isci.2022.104500 · Cited by 8

CoVEffect: interactive system for mining the effects of SARS-CoV-2 mutations and variants based on deep learning

García, G. S., Khalaf, R. A., Invernici, F., Ceri, S., & Bernasconi, A. (2022) · GigaScience · doi:10.1093/gigascience/giad036 · Cited by 8

Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression

Al-Qahtani, A. A. (2022) · Journal of International Medical Research · doi:10.1177/03000605221086433 · Cited by 8

Estimating Infection-Related Human Mobility Networks Based on Time Series Data of COVID-19 Infection in Japan

Yamada, T., & Shi, S. (2022) · Applied Sciences · doi:10.3390/app12189236 · Cited by 8

Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution

Li, L., Wei, Y., Han, Y., Yan, J., Li, X., Li, Z., Zhao, Y., Liang, H., & Wang, H. (2022) · Vaccines · doi:10.3390/vaccines10122035 · Cited by 8

Mutaciones, variantes y cepas de SARS-CoV-2

Gamero-de-Luna, E. J., & Gamero-Estévez, E. (2021) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.01.001 · Cited by 8

Genomic evolution of the SARS-CoV-2 Variants of Concern: COVID-19 pandemic waves in India

Bhardwaj, P., Mishra, S. K., Behera, S. P., Zaman, K., Kant, R., & Singh, R. (2023) · EXCLI journal · doi:10.17179/excli2023-6098 · Cited by 7

First Report of SARS-CoV-2 B.1.1.251 lineage in Brazil

dos Santos, C. A., Bezerra, G. V. B., Marinho, A. R. R. A. D. A., Sena, L. O. C., Alves, J. C., de Souza, M. S. F., Góes, M. A. D. O., Teixeira, D. C. P., Resende, P. C., Siqueira, M. M., et al. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab033 · Cited by 7

Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using in Silico Approach

Boon, S. S., Xia, C., Wang, M. H., Yip, K. L., Luk, H. Y., Li, S., Ng, R. W. Y., Lai, C. K. C., Chan, P. K. S., & Chen, Z. (2021) · mBio · doi:10.1128/mbio.02687-21 · Cited by 7

A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants

Deb, P., Molla, M. M. A., Saif‐Ur‐Rahman, K., Das, M. C., & Das, D. (2021) · Egyptian Journal of Bronchology · doi:10.1186/s43168-021-00090-x · Cited by 7

Natural Immunity Boosters as Therapeutic Interventions in the Era of the COVID-19 Pandemic

Noureen, S., Rehman, K., & Akash, M. S. H. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220110113028 · Cited by 7

Genetic variants of SARS-CoV-2 and its clinical implications

Lara, A. E., Díaz, G. E. F., Benítez, S. N. G., & Soca, P. E. M. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS

Korsun, N., Trifonova, I. T., Dobrinov, V., Grigorova, I., Angelova, S. G., & Alexiev, I. (2022) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/pipd.v49i3.73

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?

Ergören, M. Ç., Tulay, P., & Dündar, M. (2021) · The EuroBiotech Journal · doi:10.2478/ebtj-2021-0001 · Cited by 2

Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance

Dholariya, S. J., Parchwani, D. N., Singh, R., Sonagra, A. D., Motiani, A., & Patel, D. D. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00991-0 · Cited by 13

COVID Mutation and Effect on Vaccine

Tian, Z. (2022) · Applied economics and policy studies · doi:10.1007/978-981-19-0564-3_5